#People
Ms. Chandra Ganjoo appointed as Group CEO of Trivitron Healthcare
Trivitron Healthcare has announced Ms. Chandra Ganjoo as Group Chief Executive Officer
Chennai, 22nd March 2022, Trivitron Healthcare, a global medical technology company, has
announced Ms. Chandra Ganjoo as Group Chief Executive Officer (Group CEO) of Trivitron Healthcare
with immediate effect. She brings in unique experience and strong skills to lead Trivitron Healthcare
into its next phase of profitable growth.
Ms Chandra Ganjoo, joined Trivitron Healthcare in 1999 and has played several positions in the
organisation, has been a foundation of strength and progress. Since 1999, she has worked in sales,
marketing, corporate communication, human resource management, cost controller, and a variety of
other areas. She has risen in prominence, particularly in the last five years, when the company
transformed from a predominantly trading and distribution company to a global R&D and
manufacturing MNC by demonstrating exceptional compassionate people management skills, hard
work, process compliance, and commitment.
Talking about the decision, Dr. GSK Velu Chairman & Managing Director at Trivitron Group of
Companies, said, “As we embark on our journey to become an innovative, research driven MedTech
Global MNC, it is certainly a right time to put a new organisation structure in place to achieve our long
term goals and objectives. Trivitron will have three different Strategic Business Units viz India,
International & Joint Ventures, and this will be further sub-divided as multiple verticals within these
SBUs to give focus and individual successes.”
“We have a centralised corporate leadership team guiding, supporting and monitoring these verticals
and SBUs. I along with Board of Trivitron Healthcare is extremely pleased & proud to have chosen Ms
Chandra Ganjoo as Group Chief Executive Officer (Group CEO) of Trivitron Healthcare with immediate
effect. I am confident that she will lead our organisation to greater heights of success.” he said.
Ms Ganjoo has been instrumental in extending Trivitron's global footprint through several organic and
inorganic growth strategy initiatives, and has been a key driver in implementing the organization's 3
P's Strategy, which includes People, Process, and Performance.
Ms. Chandra Ganjoo, Group Chief Executive Officer at Trivitron Healthcare, said, “I thank Dr. Velu
and the board of Trivitron Healthcare for the trust and confidence reposed in me. It has been my
privilege to work at Trivitron Healthcare almost since its inception. I am humbled to have been chosen
to lead this organization and it is a moment of pride and honour for me. Trivitron’s foundation is based
on strong pillars of transparency, equality, trust, customer first attitude and committed people. With
this strong foundation and support from all Trivitronians, I will work towards the growth and success
of the group companies and all our stakeholders.”
About Trivitron Healthcare
Since 1997, the journey of Trivitron Healthcare as a medical technology company providing
affordable healthcare solutions weaves a fascinating thread of inspiration to many healthcare
providers. Having a solid expertise in research and development, Trivitron manufactures and
distributes exceptional medical technology products to 180 countries. With 15 certified
manufacturing facilities in India, USA, Finland, Turkey & China; Trivitron spearheads
innovation in the fields of COVID-19 Products, In-Vitro Diagnostics, Imaging & Radiology,
Radiation Protection, Newborn Screening, Critical Care and Operating Room Solutions, thus,
engraving its name as a holistic healthcare provider.